EP3192492B1 - Solid lip cosmetic - Google Patents
Solid lip cosmetic Download PDFInfo
- Publication number
- EP3192492B1 EP3192492B1 EP15840955.7A EP15840955A EP3192492B1 EP 3192492 B1 EP3192492 B1 EP 3192492B1 EP 15840955 A EP15840955 A EP 15840955A EP 3192492 B1 EP3192492 B1 EP 3192492B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- component
- mass
- hydrogenated polyisobutene
- lip cosmetic
- solid lip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 57
- 239000007787 solid Substances 0.000 title claims description 37
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 62
- 238000004040 coloring Methods 0.000 claims description 32
- 239000000463 material Substances 0.000 claims description 32
- 239000003607 modifier Substances 0.000 claims description 26
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 claims description 23
- 239000001993 wax Substances 0.000 claims description 19
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 claims description 15
- 229940117985 trimethyl pentaphenyl trisiloxane Drugs 0.000 claims description 14
- PHLASVAENYNAOW-UHFFFAOYSA-N methyl-bis[[methyl(diphenyl)silyl]oxy]-phenylsilane Chemical compound C=1C=CC=CC=1[Si](C)(C=1C=CC=CC=1)O[Si](C=1C=CC=CC=1)(C)O[Si](C)(C=1C=CC=CC=1)C1=CC=CC=C1 PHLASVAENYNAOW-UHFFFAOYSA-N 0.000 claims description 13
- 229920001296 polysiloxane Polymers 0.000 claims description 13
- 150000001336 alkenes Chemical class 0.000 claims description 9
- 229940008099 dimethicone Drugs 0.000 claims description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 9
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 9
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 8
- 125000003944 tolyl group Chemical group 0.000 claims description 8
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 claims description 6
- 235000010290 biphenyl Nutrition 0.000 claims description 6
- 239000004305 biphenyl Substances 0.000 claims description 6
- 125000006267 biphenyl group Chemical group 0.000 claims description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 6
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 claims description 5
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 claims description 4
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 claims description 4
- 229940057874 phenyl trimethicone Drugs 0.000 claims description 4
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 4
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 claims description 4
- QOOJEEZYYXGPAO-UHFFFAOYSA-N 2,2-bis(2-ethylhexanoyloxymethyl)butyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(CC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC QOOJEEZYYXGPAO-UHFFFAOYSA-N 0.000 claims description 3
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 claims description 3
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 claims description 3
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 claims description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 3
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims description 3
- 229940057995 liquid paraffin Drugs 0.000 claims description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 229940093625 propylene glycol monostearate Drugs 0.000 claims description 3
- 229940032094 squalane Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 description 43
- 238000011156 evaluation Methods 0.000 description 39
- 230000001681 protective effect Effects 0.000 description 32
- 239000010410 layer Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 230000005923 long-lasting effect Effects 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 239000003921 oil Substances 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 10
- 229920002545 silicone oil Polymers 0.000 description 10
- -1 diphenylsiloxy phenyl Chemical group 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 239000004698 Polyethylene Substances 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 239000000047 product Substances 0.000 description 4
- 239000002344 surface layer Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000013065 commercial product Substances 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical class CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- WEQWXQXCDKYCOY-UHFFFAOYSA-N diphenyl-trimethylsilyloxy-triphenylsilyloxysilane Chemical class C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(O[Si](C)(C)C)O[Si](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WEQWXQXCDKYCOY-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 239000012182 japan wax Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- TWSWDPUTHNETJE-UHFFFAOYSA-N methylsilyloxy-diphenyl-triphenylsilyloxysilane Chemical compound C[SiH2]O[Si](O[Si](c1ccccc1)(c1ccccc1)c1ccccc1)(c1ccccc1)c1ccccc1 TWSWDPUTHNETJE-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
- A61Q1/06—Lipsticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
Definitions
- the present invention relates to a solid lip cosmetic, and in particular, relates to a lip cosmetic having excellent secondary adhesion protective effect immediately after being applied and being excellent in gloss (luster) durability and stability.
- Patent Literatures 1 to 3 by using lip-adhering hydrogenated polyisobutene and organic silicone oil that has low compatibility with the hydrogenated polyisobutene at room temperature, solid lip cosmetics, which are homogeneous in the product but the hydrogenated polyisobutene and the organic silicone oil separate by contact during application, have been disclosed.
- the blending of coloring material is normally necessary for a solid lip cosmetic to function as a makeup cosmetic.
- the coloring material is directed more to hydrogenated polyisobutene than to organic silicone oil; therefore, the percentage of hydrogenated polyisobutene needs to be large to blend a certain amount of coloring material.
- hydrogenated polyisobutene itself is colorless and transparent, and it is an oil having various viscosities depending upon the degree of polymerization.
- the hydrogenated polyisobutene layer of lipstick tends to likely remain more on the lip, and the long-lasting property is improved.
- Patent Literature 4 relates to a solid cosmetic for lips characterized by comprising (a) 5 to 30 mass % of hydrogenated polyisobutene, (b) 30 to 70 mass % of one or more kinds of methyl phenyl silicones that separate from (a) when mixed therewith at 25 °C, (c) 0.5 to 15 mass % of oil that separates from both (a) and (b) when mixed therewith at 25 °C, and (d) 4 to 12 mass % of wax.
- the present invention was made in view of the above-described problem of the conventional art, and an object is to provide a solid lip cosmetic that has an excellent secondary adhesion protective effect and can provide the increased freedom in the blending quantity of hydrogenated polyisobutene.
- the present inventors have diligently studied to solve the above-described problem; as a result, the present inventors have found that the freedom in the selection of the blending quantity of hydrogenated polyisobutene can be increased without losing the secondary adhesion protective effect by choosing a compatibility modifier, which is blended to improve the dispersion of hydrogenated polyisobutene and organic silicone oil during production (during heating at a high temperature), thus the present invention is completed.
- the solid lip cosmetic of the present invention comprises the following components (a) to (d):
- the solid lip cosmetic comprise (e) a coloring material is contained.
- the solid lip cosmetic comprise component (e) is dispersed in component (a). It is preferable that the solid lip cosmetic comprise methyl phenyl silicone of component (b) include one or more selected from the group consisting of trimethyl pentaphenyl trisiloxane, diphenyl dimethicone, diphenylsiloxy phenyl trimethicone, and phenyl trimethicone.
- the solid lip cosmetic comprise one or more selected from the group consisting of olefin oligomer, glyceryl tri-2-ethylhexanoate, sorbitan sesquiisostearate, propylene glycol monostearate, cetyl PEG/PPG-10/1 dimethicone, diglyceryl diisostearate, glyceryl diisostearate, pentaerythrityl tetraethylhexanoate, squalane, liquid paraffin, trimethylolpropane triisostearate, trimethylolpropane triethylhexanoate, diisostearyl malate, and cetyl ethylhexanoate are further contained as the (f) compatibility modifier aid.
- olefin oligomer glyceryl tri-2-ethylhexanoate
- sorbitan sesquiisostearate propylene glycol monostearate
- solid lip cosmetic of the present invention specific amounts of (a) hydrogenated polyisobutene, (b) one or more methyl phenyl silicones that separate at 25 °C when mixed with (a), (c) neopentyl glycol dicaprate, and (d) wax are blended,
- a solid lip cosmetic excellent in the secondary adhesion resistance effect, long-lasting property, and moldability can be obtained while expanding the range of choice for the blending quantity of hydrogenated polyisobutene.
- Fig. 1 is an explanatory drawing of the affinity of various compatibility modifiers or aids to hydrogenated polyisobutene or methyl phenyl silicone.
- the solid lip cosmetic of the present invention comprises (a) hydrogenated polyisobutene, (b) one or more methyl phenyl silicones that separate at 25 °C when mixed with (a), (c) neopentyl glycol dicaprate, and (d) wax.
- Component (a) is an oil that does not dissolve in component (b). Component (a) has a higher affinity to the lip than component (b), and it likely adheres on the lip.
- the average molecular weight of the hydrogenated polyisobutene is 1000 to 2650.
- the effect due to the selection of the below-described neopentyl glycol dicaprate is prominently exhibited when the blending quantity of hydrogenated polyisobutene is 30% by mass or higher. That is, when the blending quantity of component (a) is 30% by mass or higher, the long-lasting property can be further improved while the secondary adhesion protective effect is maintained.
- the blending quantity of component (a) is 45% by mass or lower.
- the coloring material in the cosmetic cannot sufficiently be directed to the hydrogenated polyisobutene layer, and the blending quantity of the coloring material is limited. If the amount exceeds 50% by mass, moldability becomes poor, and a problem may be generated in the feeling in use such as a poor long-lasting property and the generation of stickiness; in addition, the amount of methyl phenyl silicone becomes low correspondingly, so that it can be difficult that the secondary adhesion protective effect becomes clear.
- methyl phenyl silicone used in the present invention separates when mixed with (a) hydrogenated polyisobutene at 25 °C.
- the (b) methyl phenyl silicone blended in the solid lip cosmetic of the present invention can be one kind or a mixture of two or more kinds.
- component (b) When two or more methyl phenyl silicones are used as component (b), the presence or absence of separation varies depending on the blending ratio thereof. Therefore, it is necessary to observe the presence or absence of separation according to a blending ratio of the component (b).
- methyl phenyl silicones examples include trimethyl pentaphenyl trisiloxane, diphenyl dimethicone, diphenylsiloxy phenyl trimethicone, and phenyl trimethicone.
- methyl pentaphenyl trisiloxane is preferable as (b) methyl phenyl silicone blended in the solid lip cosmetic of the present invention.
- trimethyl pentaphenyl trisiloxanes examples include methyl phenyl silicone PH-1555 (180 mm2/s (25 °C), manufactured by Dow Corning Toray Co., Ltd.) and methyl phenyl silicone FZ3156 (165 mm2/s (25 °C), manufactured by Dow Corning Toray Co., Ltd.)
- examples of diphenyl dimethicone as a commercially available product include silicone KF54 (400 mm2/s (25 °C), manufactured by Shin-Etsu Chemical Co., Ltd.), and silicone KF50-300CS (270 to 330 mm2/s (25 °C), manufactured by Shin-Etsu Chemical Co., Ltd.).
- diphenylsiloxy phenyl trimethicones examples include silicone KF56 (14 mm2/s (25 °C), manufactured by Shin-Etsu Chemical Co., Ltd.).
- phenyl trimethicone as a commercial product include silicone SH556 (22 mm2/s (25 °C), manufactured by Dow Corning Toray Co., Ltd.).
- the blending quantity of (b) hydrogenated polyisobutene is 20 to 70% by mass relative to the total amount of the cosmetic.
- the blending quantity is 30% by mass or higher. In addition, it is preferable that the blending quantity is 60% by mass or lower. If the blending quantity of component (b) is less than 20% by mass, the separation during application becomes difficult, and the secondary adhesion protective effect is not manifested. If it exceeds 70% by mass, the blending quantity of other components decreases, and the blending of coloring material becomes difficult.
- the compatibility modifier is an oil that is compatible with component (a) and component (b) at 90 °C, separates at 25 °C when mixed with component (a), and is compatible with or disperses when mixed with component (b).
- neopentyl glycol dicaprate can be listed.
- the blending quantity of (c) hydrogenated polyisobutene is 1 to 20% by mass relative to the total amount of the cosmetic.
- the blending quantity is 2% by mass or higher.
- the blending quantity is 5% by mass or higher.
- the blending quantity is 15% by mass or lower.
- blending quantity of component (c) is less than 1% by mass, (a) and (b) are not compatible at 90 °C; as a result, molding as a lipstick cannot be achieved. If the blending quantity exceeds 20% by mass, the secondary adhesion protective effect is not manifested.
- the solid lip cosmetic of the present invention when the solid lip cosmetic of the present invention is applied on the lip, component (a) and components (b) and (c) immediately separate upon the contact of the cosmetic and the lip, component (a) adheres on the lip, and components (b) and (c) with low viscosity separate to the surface layer; as a result, the secondary adhesion protective effect is manifested.
- a contact with an object such as a cup takes place in the state that such a cosmetic is applied on the skin (lip)
- only the transparent components (b) and (c) in the cosmetic adhere to the object.
- component (b) is present in a large amount
- component (b) again separates to the surface layer upon the contact of the object and the lip. Accordingly, the solid lip cosmetic of the present invention can manifest the secondary adhesion protective effect for a long time.
- wax blended in the solid lip cosmetic of the present invention is not limited in particular as long as it can be normally blended for cosmetics.
- the wax used in the present invention is compatible with the methyl phenyl silicone.
- waxes used in the present invention examples include carnauba wax, candelilla wax, polyethylene wax, beeswax, ceresin, microcrystalline wax, solid paraffin, and Japan wax.
- the blending quantity of component (d) is 3 to 12% by mass relative to the total amount of the cosmetic and preferably 4 to 12% by mass. If the blending quantity of component (d) is less than 3% by mass, the solidification is difficult. If it exceeds 12% by mass, the cosmetic becomes heavily spreadable and the gloss thereof is lost.
- components normally used in lip cosmetics can be included as optional components.
- Coloring materials can be powdery or lake-like (oil-containing state) so far as they are coloring materials normally used in lipsticks. They can be inorganic pigments, organic pigments, or pearlescent agents. Inorganic pigments, organic pigments, and pearlescent agents are all more wettable to the dispersed-phase oil component (component (a)) than to the continuous phase oil component (component (b)). Accordingly, the coloring material spontaneously moves into the dispersed-phase oil component. Therefore, the coloring material is held in (a) hydrogenated polyisobutene when the cosmetic is applied and it is present in the inner side of component (b) of surface layer; thus the secondary adhesion rarely takes place.
- component (e) is substantially dispersed in component (a). It is especially preferable that 80% by mass or more component (e) of the total amount of coloring material is dispersed in component (a).
- the blending quantity of coloring material is preferably 1 to 15% by mass relative to the total amount of the cosmetic and especial preferably 5 to 10% by mass. If the blending quantity of coloring material is too small, the secondary adhesion protective effect may be hardly believed.
- the (f) compatibility modifier aid one or more selected from the group consisting of olefin oligomer, glyceryl tri-2-ethylhexanoate, sorbitan sesquiisostearate, propylene glycol monostearate, cetyl PEG/PPG-10/1 dimethicone, diglyceryl diisostearate, glyceryl diisostearate, pentaerythrityl tetraethylhexanoate, squalane, liquid paraffin, trimethylolpropane triisostearate, trimethylolpropane triethylhexanoate, diisostearyl malate, and cetyl ethylhexanoate.
- olefin oligomer glyceryl tri-2-ethylhexanoate
- sorbitan sesquiisostearate propylene glycol monostearate
- Component (f) has high compatibility with components (a) to (c) at a high temperature (90 °C), and a more stable solid lip cosmetic can easily be prepared by blending such an oil.
- the blending quantity is preferably 1 to 20 % by mass with respect to the total amount of the cosmetic, and especially preferably 1 to 15% by mass. If the blending quantity of component (f) is less than 1% by mass, the compatibility of components (a) and (b) is poor and separation may take place. If the blending quantity exceeds 20% by mass, component (b) does not separate during its application on the lip, and the secondary adhesion protective effect may not be manifested.
- an adjuvant that exceeds the blending quantity of neopentyl glycol dicaprate, which is component (c), may lower the blending effect of neopentyl glycol dicaprate; therefore, it is preferably the equal amount or less.
- the components normally used in lip cosmetics for example, oil other than the above-described oils, powder, polymer compound, moisturizer, perfume, antioxidant agent, preservative, and beauty component
- the components normally used in lip cosmetics can be blended so far as the effect of the present invention is not undermined.
- the solid lip cosmetic of the present invention is constituted so that the separation does not take place throughout the entire production process and the state of one homogeneous phase is maintained.
- the solid lip cosmetic of the present invention can be applied to lipsticks, lip glosses, lip bases, overcoats for lipsticks, lip creams, and the like.
- a solid lipstick is preferable.
- component (b) with low viscosity and low affinity to the lip separates to the surface layer, and component (a) is present in the inner layer (lip surface).
- the coloring material has a high affinity to component (a); therefore, the coloring material is taken in the inner layer. Therefore, when a lip cosmetic sticks on the cup, only component (b) where coloring material not blended adheres to the cup. Because component (b) is present in a large amount, component (b) exudes from the lip cosmetic upon the contact of the cup and the lip. Therefore, in the above-described system, an excellent secondary adhesion protective effect can be exhibited for a long time.
- methyl phenyl silicone layer methyl phenyl silicone that adheres to a cup etc. becomes colored; thus it is necessary to localize the coloring material in the hydrogenated polyisobutene layer.
- compatibility modifiers such as sorbitan sesquiisostearate are compatible with (a) hydrogenated polyisobutene and (b) organic silicone oil at 90 °C, and they contribute to the compatibility of hydrogenated polyisobutene and organic silicone oil.
- the compatibility modifier of the above-described Patent Literatures 1 to 3 generally tend to have a higher affinity to hydrogenated polyisobutene than to methyl phenyl silicone at ordinary temperature (25 °C).
- the present inventors selects neopentyl glycol dicaprate, as the compatibility modifier, which has a higher affinity to organic silicone oil than to hydrogenated polyisobutene at ordinary temperature.
- neopentyl glycol dicaprate as the compatibility modifier, which has a higher affinity to organic silicone oil than to hydrogenated polyisobutene at ordinary temperature.
- the blending quantity of hydrogenated polyisobutene can be increased, the blending quantity of coloring material can also be increased.
- the present inventors evaluated the tranferability, for various compatibility modifiers, to the hydrogenated isobutene layer and to the organic silicone layer at ordinary temperature.
- Compatibility modifiers used in the testing are as follows from the left side in Fig. 1 ,
- neopentyl glycol dicaprate as the compatibility modifier has a higher affinity to methyl phenyl silicone than to hydrogenated polyisobutene at ordinary temperature; thus the lower layer (trimethyl pentaphenyl siloxane) increases. That is, the dilution of the hydrogenated polyisobutene layer does not take place, and good moldability can be maintained.
- diisostearyl malate, olefin oligomer, trimethylolpropane triisostearate, etc. have a high affinity to hydrogenated polyisobutene at ordinary temperature; thus the upper layer (hydrogenated polyisobutene) increases. That is, it is considered that the dilution of the hydrogenated polyisobutene layer takes place, and moldability becomes lower.
- the present inventors produced samples (solid lipsticks) with the blending compositions listed in Table 1 or 2 by a conventional method.
- the respective samples were evaluated based on the following evaluation criteria (2).
- Evaluation (2) Evaluation test of long-lasting property after 2 hours
- the actual usage test was conducted by 10 professional panelists. For evaluation, a sample was applied on the lip, and the long-lasting property (2 hours after application) was evaluated (scored) based on the following five-level sensory scoring criteria. The determination was by score average values and based on the following evaluation criteria.
- the actual usability test by 10 professional panelists was carried out.
- the five-level sensory evaluation (scoring) of the secondary adhesion protective effect upon application to the lip was based on the below-described scoring criteria.
- the determination was by the score average value based on the below-described evaluation criteria.
- the present inventors investigated the blending quantity of hydrogenated polyisobutene when neopentyl glycol dicaprate was used as the (c) compatibility modifier.
- component (c) when neopentyl glycol dicaprate is used as component (c), the secondary adhesion protective effect can be maintained even in the case that the blending quantity of component (a) is 25% by mass or higher. In addition, when the blending quantity of component (a) is 30% by mass or higher, the long-lasting property can also be improved.
- Formulation Example 1 lipstick Group of Components Components % by mass (a) hydrogenated polyisobutene 35% by mass 35.0 (b) trimethyl pentaphenyl trisiloxane 36.4 (b) diphenyl dimethicone 1.8 (c) neopentyl glycol dicaprate 7.0 (d) wax 7.0 (e) coloring material 4.6 (e) pearlescent agents 4.6 (f) pearlescent agents 3.0 (f) sorbitan sesquiisostearate 2.0
- Cosmetic (a) Group of Components Components % by mass (a) hydrogenated polyisobutene 45 (b) trimethyl pentaphenyl trisiloxane 29.9 (c) neopentyl glycol dicaprate 10 (d) wax 5 (e) coloring material 4.1 (e) pearlescent agents 1.1 (f) olefin oligomers 2.9 (f) sorbitan sesquiisostearate 2.0
- Cosmetic Example 3 lipstick Group of Component
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014183612 | 2014-09-09 | ||
PCT/JP2015/075575 WO2016039369A1 (ja) | 2014-09-09 | 2015-09-09 | 唇用固形化粧料 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3192492A1 EP3192492A1 (en) | 2017-07-19 |
EP3192492A4 EP3192492A4 (en) | 2018-03-07 |
EP3192492B1 true EP3192492B1 (en) | 2019-11-13 |
Family
ID=55459113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15840955.7A Active EP3192492B1 (en) | 2014-09-09 | 2015-09-09 | Solid lip cosmetic |
Country Status (8)
Country | Link |
---|---|
US (1) | US20170290760A1 (ja) |
EP (1) | EP3192492B1 (ja) |
JP (2) | JP6184454B2 (ja) |
KR (1) | KR102429950B1 (ja) |
CN (1) | CN106999369B (ja) |
ES (1) | ES2762699T3 (ja) |
TW (1) | TWI685353B (ja) |
WO (1) | WO2016039369A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017194581A (ja) * | 2016-04-21 | 2017-10-26 | 加藤 陽弘 | 粘着性蛍光シート及びこれを用いた発光装置 |
JP7320914B2 (ja) * | 2017-04-26 | 2023-08-04 | 株式会社 資生堂 | 透明組成物および透明化粧料 |
JP6964326B2 (ja) * | 2017-07-07 | 2021-11-10 | 紀伊産業株式会社 | 口唇化粧料及びその製造方法 |
JP7089386B2 (ja) * | 2018-03-26 | 2022-06-22 | ポーラ化成工業株式会社 | 皮膚外用組成物 |
CN112512495A (zh) * | 2018-07-31 | 2021-03-16 | 株式会社资生堂 | 皮肤仿真膜、其制造方法及使用方法、与具有该皮肤仿真膜的化妆套盒 |
JP7483686B2 (ja) * | 2019-03-28 | 2024-05-15 | 株式会社コーセー | 油性化粧料 |
JP7347515B2 (ja) * | 2019-08-26 | 2023-09-20 | 信越化学工業株式会社 | 固形化粧料 |
KR102321533B1 (ko) * | 2019-10-29 | 2021-11-04 | 코스맥스 주식회사 | 유분산 타입의 입술용 화장료 조성물 |
JP7522423B2 (ja) | 2019-10-31 | 2024-07-25 | 中野製薬株式会社 | 固形化粧料 |
JP6925086B1 (ja) * | 2021-02-25 | 2021-08-25 | 株式会社伊勢半 | 油性口唇化粧料 |
JPWO2023058469A1 (ja) * | 2021-10-08 | 2023-04-13 | ||
CN115670978A (zh) * | 2022-09-05 | 2023-02-03 | 广州卡迪莲化妆品科技有限公司 | 一种抗转移、持久光泽和舒适的化妆品、唇膏及其制备方法 |
WO2024142983A1 (ja) * | 2022-12-28 | 2024-07-04 | 株式会社 資生堂 | 唇用固形化粧料 |
WO2024142982A1 (ja) * | 2022-12-28 | 2024-07-04 | 株式会社 資生堂 | 唇用固形化粧料 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1036223A (ja) * | 1996-07-19 | 1998-02-10 | Shiseido Co Ltd | 口紅用組成物 |
FR2894471B1 (fr) * | 2005-12-08 | 2008-02-15 | Oreal | Composition cosmetique comprenant un ester d'acide dimerdilinoleique et de polyol(s), une huile volatile et un agent filmogene |
US20070134181A1 (en) * | 2005-12-08 | 2007-06-14 | L'oreal | Cosmetic composition comprising an ester of dimerdilinoleic acid and of polyol(s) and a silicone surfactant |
US8580284B2 (en) * | 2008-09-25 | 2013-11-12 | Kao Corporation | Oil-based cosmetic preparation |
US8420063B2 (en) * | 2009-03-31 | 2013-04-16 | Shiseido Company, Ltd. | Lip cosmetics |
KR101211318B1 (ko) * | 2009-11-30 | 2012-12-11 | 가부시키가이샤 시세이도 | 입술용 화장료 |
JP5926896B2 (ja) | 2010-09-17 | 2016-05-25 | 株式会社 資生堂 | 唇用固形化粧料 |
JP5280490B2 (ja) * | 2011-06-01 | 2013-09-04 | 株式会社 資生堂 | 唇用固形化粧料 |
-
2015
- 2015-09-09 CN CN201580048524.0A patent/CN106999369B/zh active Active
- 2015-09-09 WO PCT/JP2015/075575 patent/WO2016039369A1/ja active Application Filing
- 2015-09-09 TW TW104129758A patent/TWI685353B/zh active
- 2015-09-09 JP JP2015177302A patent/JP6184454B2/ja active Active
- 2015-09-09 US US15/508,329 patent/US20170290760A1/en not_active Abandoned
- 2015-09-09 ES ES15840955T patent/ES2762699T3/es active Active
- 2015-09-09 EP EP15840955.7A patent/EP3192492B1/en active Active
- 2015-09-09 KR KR1020177003953A patent/KR102429950B1/ko active IP Right Grant
-
2016
- 2016-08-01 JP JP2016151436A patent/JP6242958B2/ja active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
CN106999369B (zh) | 2021-04-13 |
TWI685353B (zh) | 2020-02-21 |
KR102429950B1 (ko) | 2022-08-04 |
EP3192492A1 (en) | 2017-07-19 |
CN106999369A (zh) | 2017-08-01 |
JP2016056173A (ja) | 2016-04-21 |
ES2762699T3 (es) | 2020-05-25 |
EP3192492A4 (en) | 2018-03-07 |
TW201613552A (en) | 2016-04-16 |
JP6242958B2 (ja) | 2017-12-06 |
US20170290760A1 (en) | 2017-10-12 |
WO2016039369A1 (ja) | 2016-03-17 |
JP2016185992A (ja) | 2016-10-27 |
KR20170045208A (ko) | 2017-04-26 |
JP6184454B2 (ja) | 2017-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3192492B1 (en) | Solid lip cosmetic | |
EP2716277B1 (en) | Solid cosmetic for lips | |
JP4757950B2 (ja) | 唇用化粧料 | |
KR102235054B1 (ko) | 끈적임이 개선된, 지속력 있고, 묻어나지 않는 화장료 조성물 | |
JP7463105B2 (ja) | 永続口唇メイクアップ用トップコート | |
US8420063B2 (en) | Lip cosmetics | |
EP2589372B1 (en) | Lip cosmetic | |
CN115702027B (zh) | 长经久性唇用化妆品系统和面涂层 | |
JP7483686B2 (ja) | 油性化粧料 | |
US11160735B1 (en) | Long wear lip cosmetic system and topcoat | |
KR102417956B1 (ko) | 입술용 화장료 조성물 | |
TWI851691B (zh) | 油性化妝料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170405 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20180206 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 8/891 20060101ALI20180131BHEP Ipc: A61Q 1/04 20060101ALI20180131BHEP Ipc: A61K 8/31 20060101AFI20180131BHEP Ipc: A61K 8/92 20060101ALI20180131BHEP Ipc: A61K 8/37 20060101ALI20180131BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20190117 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20190618 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: TOMITA, NORIKO Inventor name: NAKANO, YUSUKE Inventor name: SUZUKI, SUMIRE |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 1200928 Country of ref document: AT Kind code of ref document: T Effective date: 20191115 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602015041792 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20191113 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200213 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200214 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200213 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200313 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2762699 Country of ref document: ES Kind code of ref document: T3 Effective date: 20200525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200313 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602015041792 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1200928 Country of ref document: AT Kind code of ref document: T Effective date: 20191113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20200814 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20200909 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20200930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200909 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200909 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200909 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20220114 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200909 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200910 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191113 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230516 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602015041792 Country of ref document: DE Representative=s name: TER MEER STEINMEISTER & PARTNER PATENTANWAELTE, DE |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240820 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240820 Year of fee payment: 10 |